Millennium Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,798
| Closed | -$5.72K | – | 6512 |
|
|
2025
Q1 | $5.72K | Buy |
+10,798
| New | +$17.8K | ﹤0.01% | 5711 |
|
|
2024
Q3 | – | Sell |
-572
| Closed | -$9.27K | – | 6581 |
|
|
2024
Q2 | $9.27K | Sell |
572
-725
| -56% | -$18.2K | ﹤0.01% | 5618 |
|
|
2024
Q1 | $131K | Sell |
1,297
-426
| -25% | -$26.9K | ﹤0.01% | 5509 |
|
|
2023
Q4 | $40.7K | Sell |
1,723
-130
| -7% | -$2.19K | ﹤0.01% | 5517 |
|
|
2023
Q3 | $38.2K | Sell |
1,853
-1,099
| -37% | -$21.3K | ﹤0.01% | 5535 |
|
|
2023
Q2 | $76.7K | Sell |
2,952
-1,307
| -31% | -$37.4K | ﹤0.01% | 5386 |
|
|
2023
Q1 | $89K | Buy |
4,259
+755
| +22% | +$16.9K | ﹤0.01% | 5462 |
|
|
2022
Q4 | $71K | Sell |
3,504
-6,877
| -66% | -$130K | ﹤0.01% | 5687 |
|
|
2022
Q3 | $287K | Sell |
10,381
-4,949
| -32% | -$142K | ﹤0.01% | 5417 |
|
|
2022
Q2 | $405K | Buy |
15,330
+13,016
| +562% | +$579K | ﹤0.01% | 5122 |
|
|
2022
Q1 | $185K | Sell |
2,314
-358
| -13% | -$44.2K | ﹤0.01% | 5857 |
|
|
2021
Q4 | $545K | Buy |
+2,672
| New | +$667K | ﹤0.01% | 4967 |
|
|
2021
Q3 | – | Sell |
-2,552
| Closed | -$663K | – | 7358 |
|
|
2021
Q2 | $663K | Sell |
2,552
-1,355
| -35% | -$413K | ﹤0.01% | 5047 |
|
|
2021
Q1 | $1.51M | Buy |
+3,907
| New | +$1.58M | ﹤0.01% | 3796 |
|
Other funds holding VINC
Millennium Management's VINC Position: Q2 2025 in Review
Millennium Management sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2025, closing a stake of 10,798 shares — an estimated $5.72K sold.
Millennium Management first reported a position in VINC in Q1 2021 and held it in 14 quarters. The position peaked at $1.51M in Q1 2021. 1 fund tracked by Wall St. Rank holds VINC as of Q2 2025.
- Millennium Management reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Millennium Management sold 10,798 Vincerx Pharma, Inc. Common Stock shares in Q2 2025, an estimated $5.72K.
- Millennium Management first reported a position in Vincerx Pharma, Inc. Common Stock in Q1 2021 and held it in 14 quarters.
- Millennium Management's Vincerx Pharma, Inc. Common Stock position peaked at $1.51M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2025.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.